Minimally invasive treatment options for heart valve disease
At Main Line Health, we have a dedicated team of prominent cardiac surgeons, interventional cardiologists, cardiac imaging specialists and advanced care nurses who have specialized in diagnosing and treating heart valve disease for over 30 years.
We’re constantly seeking to treat our patients with the most effective, minimally invasive options that allow them more comfort and a quicker recovery time, so they can get back to their daily activities as soon as possible.
Our heart valve team offers a wide range of transcatheter and minimally invasive surgical treatments for individuals with heart valve disease, including:
Transcatheter options:
- Transcatheter aortic valve replacement (TAVR)
- Transcatheter mitral valve repair
- Transcatheter mitral valve replacement (TMVR)
- Transcatheter tricuspid valve replacement
- Transcatheter tricuspid valve repair
- Multivalve repair or replacement
- Balloon valvuloplasty
- Paravalvular leak closure
- Cardiac defect closure
Minimally invasive surgical options:
- Aortic valve repair or replacement
- Mitral valve repair or replacement
- Tricuspid valve repair or replacement
- Multivalve repair or replacement
- Mechanical valve replacements
- Bioprosthetic valve replacements
We also treat patients who have multivalve disease, who may need re-operation for valve disease and those who have valve disease related to prior chemotherapy or radiation therapy.
Why choose Lankenau Heart Institute for heart valve disease care
- Lankenau Heart Institute currently offers one of the largest portfolios of innovative and minimally invasive valve repair options in the country.
- We've performed more than 2,100 transcatheter aortic valve replacement (TAVR) procedures for various conditions since 2012, including more than 300 in 2022. Lankenau Medical Center is among the top 10% of highest performing TAVR centers in the nation.
- Lankenau Medical Center has earned a distinguished three-star rating from The Society of Thoracic Surgeons (STS) for its patient care and outcomes for isolated coronary artery bypass grafting (CABG) surgery, isolated aortic valve replacement (AVR) surgery and isolated mitral valve replacement and repair (MVRR) surgery. The three-star rating denotes the highest category of quality and highlights Lankenau Medical Center’s continued place among the elite institutions.
Cardiovascular clinical trials at Main Line Health
When our physicians and advance practice providers see patients, we not only evaluate them for available therapies or treatment, but we also consider new and upcoming options that might be appropriate through a clinical trial.
Learn more about the cardiovascular clinical trials currently being offered by our renowned heart and vascular team.
To schedule an appointment with a Lankenau Heart Institute specialist, call 1.866.CALL.MLH (225.5654) or use our secure online appointment request form.
